Research Impact Report 2025/26

Backing Canada's brightest science

Find out how your support in 2025/26 made it possible for the Canadian Cancer Society to invest in research for a future without cancer. 

[Dr Sarah Viehbeck appears on screen, speaking directly to the camera.]

Words on screen: Dr Sarah Viehbeck. Chief Mission Officer, Canadian Cancer Society.

Dr Sarah Viehbeck: Hello, I'm Dr Sarah Viehbeck, Chief Mission Officer of the Canadian Cancer Society. I’m thrilled to share our 2025/26 Research Impact Report, and what your support is making possible in cancer research. Last year, thanks to your generosity, we invested more than $48 million in world-leading science and innovation, enabling over 130 clinical trials and supporting 340 research projects. From helping prevent cancer before it starts to improving treatment for some of the most challenging cancers and advancing more personalized care, our funded researchers are changing lives today and shaping the future of cancer care. This work is leading to earlier detection, better treatment options, improved quality of life and more hope for people affected by cancer. We're bringing researchers, clinicians, partners and people with lived experience together. They’re challenging what's possible and changing the future of cancer care. Thank you for helping us back Canada's brightest science.

[The Canadian Cancer Society logo and the words “It takes a society” appear on screen.]

Turning possibility into progress

Behind every advancement in cancer research are people who believe a future without cancer is possible. 

A clinical trial that gives new hope. A prevention discovery that lowers cancer risk. A test that makes treatment more precise. Support that helps a cancer survivor’s body and mind feel stronger. These are the breakthroughs your generosity helps set in motion. 

At the Canadian Cancer Society (CCS), we’re proud to back Canada’s brightest science – bold, collaborative and focused on what matters most to people affected by cancer. With donor and partner support, we fund promising ideas from cancer prevention and early detection to treatment, recovery, survivorship and end-of-life care. 

Last year, thanks to your generosity, we invested $48.32 million in world-leading research and innovation, making over 130 clinical trials and 340 research projects possible. In this report, you’ll read about the impact of that investment. You’ll learn about how CCS-funded researchers are preventing ovarian cancer, improving treatment for brain cancer, personalizing care for people with metastatic disease and more. 

This progress doesn’t happen in isolation. It takes skilled researchers, clinicians, partners, people with lived and living experience and communities working together. It takes ongoing funding that gives research teams the people, tools and time to ask bigger questions and pursue answers that can change lives forever. 

For everyone who has faced cancer, cared for someone with cancer or feared what a diagnosis could mean, this work is about more than discovery. It’s about hope. It’s a path toward earlier answers, better options, fewer side effects and more time with the people we love. 

Thank you for helping CCS back the science and the people shaping a better future for everyone. Together, we are increasing cancer survival, stopping cancer before it starts and improving the lives of people affected by cancer.

Sincerely,

Andrea Seale

Andrea Seale 
​
Chief Executive Officer
Canadian Cancer Society 

Dr Jennifer Jones - Scientific Chair, Advisory Council on Research Canadian Cancer Society

Dr Jennifer Jones 
​
Scientific Chair, Advisory Council on Research
Canadian Cancer Society 

Headshot of CCS-funded researcher Dr Christopher Maxwell
Research takes communities: of scientists, clinical professionals, patient partners and donors. Donations, whatever the amount, are the foundation of research upon which the other communities can be built.
Dr Christopher Maxwell, CCS-funded researcher

Our research at a glance

Climbing towards HIMALAYAS

Many young people living beyond cancer face late effects, including an increased risk of heart disease. That’s why Dr Paaladinesh Thavendiranathan and his colleagues started the HIMALAYAS trial – a structured, supervised exercise program designed to improve young cancer survivors’ long-term health.

Protecting those who protect us

Firefighters face a high risk of exposure to cancer-causing substances in their work, but many don’t know how best to protect themselves. Dr Patrick McGrath and his colleagues have created the first scientific tools designed to measure cancer prevention behaviours and support better health. 

Improving immunotherapy for advanced cancer

When cancer returns, every moment counts – especially with treatments like CAR T- cell therapy, which are most effective when given early. Dr Nathalie Johnson and her team have developed a test to spot lymphoma recurrence earlier, helping people receive the right treatment at the right time. 
Headshot of Anthony Vallée, living with cancer
Research, for us, is particularly important, because it’s what makes the difference between life and death.
Anthony Vallée, living with cancer

Help fund world-leading cancer research

With almost half of all Canadians expected to face a cancer diagnosis in their lifetime, the urgency for funding is at an all-time high. Research holds the key to transforming the future of cancer.

If everyone reading this joins our monthly donor community today, we can keep up the momentum for life-changing discoveries to better detect, diagnose and treat all types of cancer.

Please donate today because every contribution counts.